Tasigna (Nilotinib)

Tasigna Nilotinib Wholesaler, Tasigna Nilotinib Distributor

Tasigna (Nilotinib) Wholesaler

Tasigna (Nilotinib)  , wholesaler

TASIGNA (NILOTINIB) DESCRIPTION:

Tasigna is targeted therapy. Tasigna is classified as a signal transduction inhibitor – protein-tyrosine kinase inhibitor

TASIGNA (NILOTINIB) INDICATIONS:

Adult And Pediatric Patients With Newly Diagnosed Ph+ CML-CP

Tasigna (nilotinib) is indicated for the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

Adult Patients With Resistant Or Intolerant Ph+ CML-CP And CML-AP

Tasigna is indicated for the treatment of adult patients with chronic phase and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included imatinib.

Pediatric Patients With Resistant Or Intolerant Ph+ CML-CP

Tasigna is indicated for the treatment of pediatric patients greater than or equal to 1 year of age with chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) with resistance or intolerance to prior tyrosine-kinase inhibitor (TKI) therapy.

DOSAGE FORM & STRENGTH:

  • Tasigna 150mg  distributor, supplier, wholesaler
  • Tasigna 200mg wholesaler

Rasso Swiss Pharma is a Tasigna distributor, supplier and wholesaler for.

<< Back to products